Development and validation of a dissolution test for rabeprazole sodium in coated tablets

Journal of Pharmaceutical and Biomedical Analysis

Volumn 41, Issue 3, 2006, Pages 833-837

  Garcia, Cassia V ^a   Paim, Clesio S ^a   Steppe, Martin ^a   Schapoval, Elfrides E S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Dissolution test; HPLC; Method validation; Quality control; Rabeprazole sodium; Stability

Indexed keywords

ACID; BASE; BORIC ACID; BUFFER; HYDROCHLORIC ACID; RABEPRAZOLE;

ARTICLE; DISSOLUTION; DRUG FORMULATION; DRUG STABILITY; METHODOLOGY; PH; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; BENZIMIDAZOLES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROGEN-ION CONCENTRATION; OMEPRAZOLE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS;

EID: 33646424082     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.01.050     Document Type: Article

References (23)

1. Furlanetto S., Maestrelli F., Orlandini S., Pinzauti S., and Mura P. J. Pharm. Biomed. Anal. 32 (2003) 159-165
2. Frost S.M.A. Dissol. Tech. Feb. (2004) 19-21
3. Ansel H., Allen Jr. L., and Popovich N. Pharmaceutical Dosage Forms and Drug Delivery Systems. 7th ed. (1999), Lippincott Williams & Wilkins, Baltimore
4. Carswell C., and Goa K. Drugs 61 (2001) 2327-2356
5. Janssen-Cilag. Pariet (1999) 1-30
6. Takakuwa S., Chiku S., Nakata H., Yuzuriha T., Mano N., and Asakawa N. J. Chromatogr. B 673 (1995) 113-122
7. Mano N., Oda Y., Takakuwa S., Chiku S., Nakata H., and Asakawa N. J. Pharm. Sci. 85 (1996) 903-907
8. Nakai H., Shimamura Y., Kanazawa T., Yasuda S., and Kayano M. J. Chromatogr. B 660 (1994) 211-220
9. Zhang Y., Chen X., Gu Q., and Zhong D. Anal. Chim. Acta 523 (2004) 171-175
10. Ramakrishna N., Vishwottam K., Wishu S., Koteshwara M., and Kumar S. J. Chromatogr. B 816 (2005) 209-214
11. Singh S., Jain M., Shah H., Gupta S., Thakker P., Shah R., and Lohray B. J. Chromatogr. B 813 (2004) 247-254
12. El-Gindy A., El-Yazby F., and Maher M. J. Pharm. Biomed. Anal. 31 (2003) 229-242
13. Garcia C.V., Paim C.S., and Steppe M. J. AOAC Int. 87 (2004) 842-846
14. Radi A., Abd El-Ghany N., and Wahdan T. Il Fármaco 59 (2004) 515-518
15. Garcia C.V., Sippel J., Sfair L., Garcia S., Jablonski A., Steppe M., and Schapoval E.E.S. J. AOAC Int. 88 (2005) 1081-1085
16. The United States Pharmacopoeia. 28th ed. (2005), United States Pharmacopoeial Convention, Rockville
17. Skoug J.W., Halstead G., Theis D.L., Freeman J., Fagam D., and Rohrs B.R. Pharm Tech. 20 (1996) 58-72
18. Marques M.R.C., and Brown W. Analytica 1 (2002) 48-51
19. ICH Q2B, International Conference on Harmonisation, Validation of analytical procedures. Methodology, 1996.
20. Farmacopéia Brasileira, 4th ed., Atheneu, Rio de Janeiro, 1988.
21. The United States Pharmacopoeia. Pharmacopeial Forum 30 (2004) 351-363
22. FDA. Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms (1997), Food and Drug Administration, Rockville
23. Farinha A., Bica A., Martins J.M., and Pais J.P. Drug Dev. Ind. Pharm. 26 (2000) 785-790